These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. A novel TAZ gene mutation and mosaicism in a Polish family with Barth syndrome. Zapała B; Płatek T; Wybrańska I Ann Hum Genet; 2015 May; 79(3):218-24. PubMed ID: 25776009 [TBL] [Abstract][Full Text] [Related]
46. Increased mtDNA Abundance and Improved Function in Human Barth Syndrome Patient Fibroblasts Following AAV- Suzuki-Hatano S; Sriramvenugopal M; Ramanathan M; Soustek M; Byrne BJ; Cade WT; Kang PB; Pacak CA Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336787 [TBL] [Abstract][Full Text] [Related]
48. Tafazzin deficiency causes substantial remodeling in the lipidome of a mouse model of Barth Syndrome cardiomyopathy. Hachmann M; Gülcan G; Rajendran R; Höring M; Liebisch G; Bachhuka A; Kohlhaas M; Maack C; Ergün S; Dudek J; Karnati S Front Mol Med; 2024; 4():1389456. PubMed ID: 39086433 [TBL] [Abstract][Full Text] [Related]
51. A novel mutation in the G4.5 (TAZ) gene in a Greek patient with Barth syndrome. Bachou T; Giannakopoulos A; Trapali C; Vazeou A; Kattamis A Blood Cells Mol Dis; 2009; 42(3):262-4. PubMed ID: 19261493 [TBL] [Abstract][Full Text] [Related]
52. Barth Syndrome: From Mitochondrial Dysfunctions Associated with Aberrant Production of Reactive Oxygen Species to Pluripotent Stem Cell Studies. Saric A; Andreau K; Armand AS; Møller IM; Petit PX Front Genet; 2015; 6():359. PubMed ID: 26834781 [TBL] [Abstract][Full Text] [Related]
53. Defining functional classes of Barth syndrome mutation in humans. Lu YW; Galbraith L; Herndon JD; Lu YL; Pras-Raves M; Vervaart M; Van Kampen A; Luyf A; Koehler CM; McCaffery JM; Gottlieb E; Vaz FM; Claypool SM Hum Mol Genet; 2016 May; 25(9):1754-70. PubMed ID: 26908608 [TBL] [Abstract][Full Text] [Related]
54. The Function of Tafazzin, a Mitochondrial Phospholipid-Lysophospholipid Acyltransferase. Schlame M; Xu Y J Mol Biol; 2020 Aug; 432(18):5043-5051. PubMed ID: 32234310 [TBL] [Abstract][Full Text] [Related]
55. Tafazzin knockdown in mice leads to a developmental cardiomyopathy with early diastolic dysfunction preceding myocardial noncompaction. Phoon CK; Acehan D; Schlame M; Stokes DL; Edelman-Novemsky I; Yu D; Xu Y; Viswanathan N; Ren M J Am Heart Assoc; 2012 Apr; 1(2):. PubMed ID: 23130124 [TBL] [Abstract][Full Text] [Related]
56. Aberrant cardiolipin metabolism is associated with cognitive deficiency and hippocampal alteration in tafazzin knockdown mice. Cole LK; Kim JH; Amoscato AA; Tyurina YY; Bay R H; Karimi B; Siddiqui TJ; Kagan VE; Hatch GM; Kauppinen TM Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3353-3367. PubMed ID: 30055293 [TBL] [Abstract][Full Text] [Related]
57. Expression of human monolysocardiolipin acyltransferase-1 improves mitochondrial function in Barth syndrome lymphoblasts. Mejia EM; Zegallai H; Bouchard ED; Banerji V; Ravandi A; Hatch GM J Biol Chem; 2018 May; 293(20):7564-7577. PubMed ID: 29563154 [TBL] [Abstract][Full Text] [Related]
58. Cardiolipin-deficient cells have decreased levels of the iron-sulfur biogenesis protein frataxin. Li Y; Lou W; Grevel A; Böttinger L; Liang Z; Ji J; Patil VA; Liu J; Ye C; Hüttemann M; Becker T; Greenberg ML J Biol Chem; 2020 Aug; 295(33):11928-11937. PubMed ID: 32636300 [TBL] [Abstract][Full Text] [Related]
59. Cardiac metabolic pathways affected in the mouse model of barth syndrome. Huang Y; Powers C; Madala SK; Greis KD; Haffey WD; Towbin JA; Purevjav E; Javadov S; Strauss AW; Khuchua Z PLoS One; 2015; 10(6):e0128561. PubMed ID: 26030409 [TBL] [Abstract][Full Text] [Related]
60. Decreased pyruvate dehydrogenase activity in Tafazzin-deficient cells is caused by dysregulation of pyruvate dehydrogenase phosphatase 1 (PDP1). Liang Z; Ralph-Epps T; Schmidtke MW; Kumar V; Greenberg ML J Biol Chem; 2024 Mar; 300(3):105697. PubMed ID: 38301889 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]